Skip to Content

2022 treatment options for transplant-ineligible patients with multiple myeloma

In this MEDtalk, Frederik Schjesvold, Head of Oslo Myeloma Center in Norway, sums up the three lines of treatment options for transplant-ineligible patients with multiple myeloma. In the first line there is a clear first choice, depending on reimbursement. In the second-line the treatment option depends on what the patient received in the first line. The third line regimen is more complex because there are some added options, and the choice depends on what treatment regimen was chosen for first and second line. See the MEDtalk and get all the details in the sequencing and treatment lines.

Fredrik Schjesvold

Lue artikkeli

Jos olet lääkäri, farmaseutti tai rajatun lääkkeenmääräämisoikeuden omaava sairaanhoitaja, pääset lukemaan artikkelin kirjautumalla käyttäjäksi BestPractice Nordic -sivustolle.

Back to top